Associations of ARHGAP26 Polymorphisms with Alzheimer’s Disease and Cardiovascular Disease
Document Type
Article
Publication Date
2-16-2022
Abstract
The Rho GTPase activating protein 26 (ARHGAP26) gene has been reported to be associated with neuropsychiatric diseases and neurodegenerative diseases including Parkinson’s disease. We examined whether the ARHGAP26 gene is associated with Alzheimer’s disease (AD) and/or cardiovascular disease (CVD). Multivariable logistic regression model was used to examine the associations of 154 single nucleotide polymorphisms (SNPs) within the ARHGAP26 gene with AD and CVD using the Alzheimer’s Disease Neuroimaging Initiative 1 (ADNI-1) cohort. Fourteen SNPs were associated with AD (top SNP rs3776362 with p = 3.43 × 10−3), while 37 SNPs revealed associations with CVD (top SNP rs415235 with p = 2.06 × 10−4). Interestingly, 13 SNPs were associated with both AD and CVD. SNP rs3776362 was associated with CVD, Functional Activities Questionnaire (FAQ), and Clinical Dementia Rating Sum of Boxes (CDR-SB). A replication study using a Caribbean Hispanics sample showed that 17 SNPs revealed associations with AD, and 12 SNPs were associated with CVD. The third sample using a family-based study design showed that 9 SNPs were associated with AD, and 3 SNPs were associated with CVD. SNP rs6836509 within the ARHGAP10 gene (an important paralogon of ARHGAP26) was associated with AD and cerebrospinal fluid total tau (t-tau) level in the ADNI sample. Several SNPs were functionally important using the RegulomeDB, while a number of SNPs were associated with significant expression quantitative trait loci (eQTLs) using Genotype-Tissue Expression (GTEx) databases. In conclusion, genetic variants within ARHGAP26 were associated with AD and CVD. These findings add important new insights into the potentially shared pathogenesis of AD and CVD.
Recommended Citation
Wang, K., Lu, Y., Morrow, D.F. et al. Associations of ARHGAP26 Polymorphisms with Alzheimer’s Disease and Cardiovascular Disease. J Mol Neurosci 72, 1085–1097 (2022). https://doi.org/10.1007/s12031-022-01972-5
Publication Title
Journal of Molecular Neuroscience
DOI
10.1007/s12031-022-01972-5
Comments
Copyright © 2022, The Author(s), under exclusive licence to Springer Science Business Media, LLC, part of Springer Nature
https://rdcu.be/cOtrC